LIRAGLUTIDE ESCALATED TO 3.0 MG REDUCES HEPATIC STEATOSIS DURING 16 WEEKS' TREATMENT IN NON-DIABETIC OBESE PATIENTS

被引：0
|
作者：
Wang, Xiao Jing
Gong, Ping
Zhou, Chenyun
Huang, Chengwu
Lok, U-Wai
Tang, Shanshan
Taylor, Ann
Eckert, Deborah J.
Chen, Shigao
Camilleri, Michael
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
445
引用
收藏
页码：S86 / S86
页数：1
相关论文
共 42 条
  • [1] Liraglutide reduces attenuation coefficient as a measure of hepatic steatosis during 16 weeks' treatment in nondiabetic obese patients: A pilot trial
    Wang, Xiao Jing
    Gong, Ping
    Zhou, Chenyun
    Huang, Chengwu
    Lok, U-Wai
    Tang, Shanshan
    Taylor, Ann
    Eckert, Deborah
    Chen, Shigao
    Camilleri, Michael
    JGH OPEN, 2021, 5 (02): : 193 - 198
  • [2] The Efficacy and Safety of Liraglutide 3.0 mg for Weight Management in Obese Non-Diabetic Saudi Outpatients
    Albaker, Waleed
    Al Sheikh, Mona
    Albakr, Aishah
    Alkhafaji, Dania
    Al Besher, Eman
    Al-Hariri, Mohammed
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 8643 - 8650
  • [3] Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
    Lesley Hoyles
    José-Manuel Fernández-Real
    Massimo Federici
    Matteo Serino
    James Abbott
    Julie Charpentier
    Christophe Heymes
    Jèssica Latorre Luque
    Elodie Anthony
    Richard H. Barton
    Julien Chilloux
    Antonis Myridakis
    Laura Martinez-Gili
    José Maria Moreno-Navarrete
    Fadila Benhamed
    Vincent Azalbert
    Vincent Blasco-Baque
    Josep Puig
    Gemma Xifra
    Wifredo Ricart
    Christopher Tomlinson
    Mark Woodbridge
    Marina Cardellini
    Francesca Davato
    Iris Cardolini
    Ottavia Porzio
    Paolo Gentileschi
    Frédéric Lopez
    Fabienne Foufelle
    Sarah A. Butcher
    Elaine Holmes
    Jeremy K. Nicholson
    Catherine Postic
    Rémy Burcelin
    Marc-Emmanuel Dumas
    Nature Medicine, 2018, 24 : 1070 - 1080
  • [4] Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
    Hoyles, Lesley
    Fernandez-Real, Jose-Manuel
    Federici, Massimo
    Serino, Matteo
    Abbott, James
    Charpentier, Julie
    Heymes, Christophe
    Latorre Luque, Jessica
    Anthony, Elodie
    Barton, Richard H.
    Chilloux, Julien
    Myridakis, Antonis
    Martinez-Gili, Laura
    Maria Moreno-Navarrete, Jose
    Benhamed, Fadila
    Azalbert, Vincent
    Blasco-Baque, Vincent
    Puig, Josep
    Xifra, Gemma
    Ricart, Wifredo
    Tomlinson, Christopher
    Woodbridge, Mark
    Cardellini, Marina
    Davato, Francesca
    Cardolini, Iris
    Porzio, Ottavia
    Gentileschi, Paolo
    Lopez, Frederic
    Foufelle, Fabienne
    Butcher, Sarah A.
    Holmes, Elaine
    Nicholson, Jeremy K.
    Postic, Catherine
    Burcelin, Remy
    Dumas, Marc-Emmanuel
    NATURE MEDICINE, 2018, 24 (07) : 1070 - +
  • [5] Efficacy and safety of liraglutide 3.0 mg in obese diabetic and non-diabetic patients-A systematic review and meta-analysis of randomised controlled trials (vol 16, e14367, 2021)
    Konwar, Mahanjit
    Ravi, Renju
    Maurya, Miteshkumar
    Bose, Debdipta
    Jaiswal, Sanjeet Kumar
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (12)
  • [6] Publisher Correction: Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
    Lesley Hoyles
    José-Manuel Fernández-Real
    Massimo Federici
    Matteo Serino
    James Abbott
    Julie Charpentier
    Christophe Heymes
    Jèssica Latorre Luque
    Elodie Anthony
    Richard H. Barton
    Julien Chilloux
    Antonis Myridakis
    Laura Martinez-Gili
    José Maria Moreno-Navarrete
    Fadila Benhamed
    Vincent Azalbert
    Vincent Blasco-Baque
    Josep Puig
    Gemma Xifra
    Wifredo Ricart
    Christopher Tomlinson
    Mark Woodbridge
    Marina Cardellini
    Francesca Davato
    Iris Cardolini
    Ottavia Porzio
    Paolo Gentileschi
    Frédéric Lopez
    Fabienne Foufelle
    Sarah A. Butcher
    Elaine Holmes
    Jeremy K. Nicholson
    Catherine Postic
    Rémy Burcelin
    Marc-Emmanuel Dumas
    Nature Medicine, 2018, 24 : 1628 - 1628
  • [7] Inhibition of beta-oxidation improves hepatic steatosis and metabolism in obese non-diabetic humans
    Borra, Ronald
    Maggio, Romina
    Kankaanpaeae, Mikko
    Parkkola, Riitta
    Naum, Alexandru
    Tuunanen, Helena
    Nagren, Kjell
    Viljanen, Tapio
    Ferrannini, Ele
    Nuutila, Pirjo
    Iozzo, Patricia
    DIABETES, 2007, 56 : A393 - A393
  • [8] Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients
    Paquot, N
    Scheen, AJ
    Dirlewanger, M
    Lefèbvre, PJ
    Tappy, L
    OBESITY RESEARCH, 2002, 10 (03): : 129 - 134
  • [9] The clinical and systemic effects of periodontal treatment in diabetic and non-diabetic obese patients
    Tasdemir, Zekeriya
    Tasdemir, Funda Ozsari
    Kocyigit, Ismail
    Yazici, Cevat
    Gurgan, Cem A.
    JOURNAL OF ORAL SCIENCE, 2016, 58 (04) : 523 - 531
  • [10] Effect of liraglutide 3.0mg treatment on weight reduction in obese antipsychotic-treated patients
    Lee, Seung Eun
    Lee, Nam Young
    Kim, Se Hyun
    Kim, Kyoung-Ah
    Kim, Yong Sik
    PSYCHIATRY RESEARCH, 2021, 299
12345